Tehran University of Medical Sciences Journal of Medical Bacteriology 2251-8649 1 3-4 2015 10 12 10 16 EN Gholamreza Goudarzi Department of Microbiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, IR Iran. Jalil Fallah-Mehrabadi The Lister Institute of Microbiology, Tehran, IR Iran. Fatemeh Farahani-Hatamabadi Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, IR Iran. Hedroosha Molla-Agha-Mirzaei The Lister Institute of Microbiology, Tehran, IR Iran. Sarah Najafi Pharmaceutical Incubator Center, Tehran University of Medical Sciences, Tehran, IR Iran. 2015 10 12 2015 10 12 Background: The prevalence of Urinary Tract Infection (UTI) is really high in the world. Escherichia coli is a major agent of UTI. One of the strategies for decreasing UTI infections is vaccine development. As the attachment is a really important stage in colonization and infection, at- tachment inhibition has an applied strategy.  FimH protein is a major factor during bacterial colonization in urinary tract and could be used as a vaccine. Thus, it was considered in this research as a candidate anti- gen. Methods: The sequences of fimH and acmA genes were used for de- signing a synthetic gene. It was cloned to pET23a expression vector and transformed  to E. coli (DE3) Origami.  To confirm the expression  of recombinant  protein,  SDS-PAGE  and western  blotting  methods  were used.  Subsequently,  recombinant  protein  was  purified.  On  the  other hand, Lactobacillus reuteri was cultured and mixed with FimH / AcmA recombinant  protein. The rate of protein localization  on lactobacillus surface was assessed using ELISA method. Results: It was showed that the recombinant protein was expressed in E. coli (DE3) Origami and purified by affinity chromatography. More- over, this protein could be localized on lactobacillus surface by 5 days. Conclusion:  In current study,  a fusion recombinant  protein was pre- pared and displayed on L. reuteri surface. This strain could be used for animal  experiment  as  a  competitor  against  Uropathogenic   E.  coli (UPEC). Using manipulated probiotics strains instead of antibiotic ther- apy could decrease the antibiotic consumption  and reduce multi-drug resistant strains. https://jmb.tums.ac.ir/index.php/jmb/article/view/18 https://jmb.tums.ac.ir/index.php/jmb/article/download/18/14